OSR Health獲Nasdaq確認忠誠度CVR計劃不觸發股價調整 8月14日為記錄日期

EX-99.1
2
ea030011101ex99-1.htm
PRESS RELEASE, DATED JULY 31, 2026, TITLED "OSR HEALTH SECURES NASDAQ COMMUNICATION: LOYALTY CVR PROGRAM WILL NOT TRIGGER A PRICE ADJUSTMENT"

 

Exhibit 99.1

 

OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will
Not Trigger a Price Adjustment

 

Bellevue, WA — July 31, 2026 — OSR Health, Inc.
(NASDAQ: OSRH) (“OSR Health” or the “Company”) today announced that The Nasdaq Stock Market (“Nasdaq”)
stated in a verbal communication with the Company that the Company’s Shareholder Loyalty Contingent Value Rights (CVR) program
will not result in any mechanical adjustment to the price of OSR Health’s common stock — either upon the distribution of
the CVRs or upon the delivery of additional shares of common stock to enrolled holders under the program.

 

What this means for shareholders:

 

●No mechanical price adjustment. Nasdaq will not apply an ex-date or other downward adjustment to the OSRH share price in connection
with the CVR distribution or the delivery of additional shares.

 

●Purely additive. Enrolled holders receive additional shares at no cost as the program’s price milestones are met.

 

●Market-determined value. The value of OSRH shares will be set by the market — not adjusted by the exchange.

 

●Record date: August 14, 2026. Hold your shares by this date to be eligible.

 

“This communication with Nasdaq provides clarity on an important
structural question about our CVR Program,” said Peter Hwang, CEO of OSR Health. “Investors who enroll and hold will receive
additional shares – and the value of those shares will be determined entirely by the market’s assessment of what we are building,
not by any mechanical “ex date” adjustment. The communication affirms that our loyalty program is additive, and gives shareholders
clarity as they approach the August 14 record date.”

 

Under the Shareholder Loyalty CVR program, shareholders of record as
of the Record Date, August 14, 2026 who complete Enrollment are eligible to receive one CVR for each share of OSRH common stock held.
Enrolled shareholders who hold their shares continuously are eligible to receive additional shares of common stock, at no cost, as defined
closing-price thresholds are met at four measurement dates over the following twelve months. Details of the program, eligibility, and
enrollment instructions for both U.S. and non-U.S. shareholders are available at www.osr-health.com/loyaltyprogram

 

The reference to Nasdaq’s position described above relates solely
to the exchange’s treatment of the CVR distribution and related share deliveries for price-adjustment purposes. It does not constitute
an endorsement of the program or of an investment in OSRH, and it does not address the separate securities-law requirements applicable
to the distribution of the CVRs and the delivery of shares, which remain subject to the Company’s ongoing regulatory process as
previously disclosed.

 

  

 

 

 

“Our priority now is making enrollment as clear and straightforward as possible, so that every eligible shareholder is positioned
to reap the full benefit of this innovative program should its price milestones be reached,” said Tim Smith, Head of Investor Relations
at OSR Health. “We don’t want a single shareholder who wishes to participate to miss out over a process step. We’re
here to help maximize participation for the shareholders who believe in what we’re building.”

 

About OSR Health

 

OSR Health, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and
wellness. Through its subsidiaries, OSR Holdings engages in immuno-oncology, regenerative biologics, and medical device technologies to
improve health outcomes worldwide. Learn more at www.osr-health.com

 

Investor Contact

 

OSR Health, Inc.
Investor Relations
[email protected]
 

Forward-Looking Statements

 

This press release contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Shareholder
Loyalty CVR program, its treatment by Nasdaq, and the potential delivery of additional shares. These statements are subject to risks
and uncertainties, including the satisfaction of the program’s holding-period and price conditions, the outcome and timing of the
Company’s separate securities-law and regulatory processes, the Company’s continued listing on Nasdaq, and other factors
described in the Company’s filings with the SEC. Actual results may differ materially. The Company undertakes no obligation to
update any forward-looking statement except as required by law. This release does not constitute an offer to sell or a solicitation of
an offer to buy any securities.